{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-104812","form_type":"8-K","ticker":"NWBO","cik":"0001072379","company_name":"NORTHWEST BIOTHERAPEUTICS INC","filed_at":"2025-10-31T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.726747+00:00","generated_at":"2026-05-17T01:03:17.767762+00:00","sec_items":["1.01","2.03"],"event_type":"debt","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"NW Biotherapeutics enters $5.5M loan agreement with Streeterville Capital","bullets":["Loan amount $5,505,000; maturity 22 months; interest 8% p.a.; 10% original issue discount.","No payments for first 8 months; 14 equal monthly installments start June 2026 at 110% pro rata principal plus interest.","Prepayment allowed with 10% charge; funds used for ongoing business operations.","Loan includes customary default provisions and potential acceleration."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-104812","json":"https://secwatch.observer/filing/0001104659-25-104812.json","markdown":"https://secwatch.observer/filing/0001104659-25-104812.md","text":"https://secwatch.observer/filing/0001104659-25-104812.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1072379/000110465925104812/0001104659-25-104812-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1072379/000110465925104812/tm2529815d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T01:03:17.767762+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"be74415a41f11098e04557eaab241d9e5ef4f774","claim":"NORTHWEST BIOTHERAPEUTICS INC incurred loan of $5,505,000 with Streeterville Capital, LLC at 8% per annum maturing 22 months.","evidence_excerpt":"On October 27, 2025, Northwest Biotherapeutics, Inc. (the “Company”) entered into a Commercial Loan Agreement and Note (collectively, the “Loan Agreement”) with Streeterville Capital, LLC (the “Holder”) in the amount of $5,505,000.","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1072379/000110465925104812/0001104659-25-104812-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"loan"},{"label":"Principal","value":"$5,505,000"},{"label":"Counterparty","value":"Streeterville Capital, LLC"},{"label":"Rate","value":"8% per annum"},{"label":"Maturity","value":"22 months"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}